Results 151 to 160 of about 19,315 (197)

Comparison of clinical efficacy and bleeding risk between ticagrelor and clopidogrel in elderly patients after percutaneous coronary intervention: A retrospective study. [PDF]

Medicine (Baltimore)
Luo J, Liang G, Chen A.
europepmc   +1 more source

Subacute Stent Thrombosis Revealing High On-Treatment Platelet Reactivity to Clopidogrel: A Case Report. [PDF]

Cureus
Nabhan E, Andriamihary O, Naoum Nehme E, Vana AP, Poulos N.   +4 more
europepmc   +1 more source

Redefining Dual Antiplatelet Strategies After Acute Coronary Syndrome: Insights from Recent RCTs. [PDF]

J Clin Med
He M, Magdy J, Aziz M, Tan J, Das A, Wheatcroft SB, Bulluck H.   +6 more
europepmc   +1 more source

Safety and Efficacy Comparison of Ticagrelor versus Other P2Y12 Inhibitors in Combination with Oral Anticoagulants as a Part of DAPT/SAPT in Patients with Concomitant Atrial Fibrillation and Coronary Artery Disease: A Meta-Analysis. [PDF]

Ther Clin Risk Manag
Li Y, Gong J, Liu N.
europepmc   +1 more source

Ticagrelor-induced sinus pause: an adenosine-driven side effect. [PDF]

BMJ Case Rep
Fanning JK, Barnes AAB, Betley F, Sondhi S.   +3 more
europepmc   +1 more source

Effect of insulin resistance on ticagrelor-versus clopidogrel-based dual antiplatelet therapy for secondary prevention of stroke in carriers of <i>CYP2C19</i> loss-of-function mutations. [PDF]

CMAJ
Zhao J, Tian X, Yang X, Xu Q, Xia X, Zhang Y, Xie X, Bath PM, Jing J, Wang Y, Meng X, Wang A.   +11 more
europepmc   +1 more source

Intravenous cangrelor as rescue therapy for acute thrombosis in neuroendovascular procedures: illustrative cases. [PDF]

J Neurosurg Case Lessons
Sahin ME, Fulton AT, Deshpande S, Alkhalili K, Hauck EF.   +4 more
europepmc   +1 more source

CYP2C19 genotype-guided escalation to ticagrelor vs. clopidogrel in secondary stroke prevention: a retrospective cohort study. [PDF]

Front Pharmacol
Haidong S, Min D, Hong Y, Jing Y.
europepmc   +1 more source